ST-segment-elevation myocardial infarction: guidelines and the challenge of real-world patient care

Sarah A Spinler1

  • 1Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania 19104, USA. s.spinle@usip.edu

Pharmacotherapy
|July 26, 2006
PubMed

Insights

Early intervention for ST-segment-elevation myocardial infarction (STEMI) is crucial. Coordinated care and strategies like prehospital fibrinolysis followed by percutaneous coronary intervention (PCI) aim to speed up treatment and improve patient outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • ST-segment-elevation myocardial infarction (STEMI) necessitates rapid reperfusion to minimize myocardial damage and mortality.
  • Existing evidence-based guidelines highlight the importance of early reperfusion in STEMI management.
  • Treatment delays remain a significant barrier to optimal STEMI care, impacting outcomes with fibrinolytic therapy and percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To review the impact of coordinated STEMI management on treatment timeliness and patient outcomes.
  • To explore novel therapeutic strategies, such as facilitated PCI, for improving STEMI care.
  • To assess the potential of prehospital interventions in conjunction with PCI for STEMI patients.

Main Methods:

  • Analysis of coordinated STEMI management involving multidisciplinary teams including emergency medical technicians, physicians, cardiologists, nurses, and administrators.
  • Investigation of facilitated PCI strategies, including prehospital fibrinolysis followed by immediate PCI.
  • Review of ongoing studies evaluating the efficacy of these advanced treatment approaches.

Main Results:

  • Coordinated STEMI management has demonstrated improvements in treatment delays and patient outcomes.
  • Multidisciplinary team involvement has been key to enhancing the efficiency of STEMI care.
  • Facilitated PCI, involving prehospital interventions, shows promise in shortening reperfusion times.

Conclusions:

  • Enhanced coordination of care significantly improves STEMI management and patient outcomes.
  • Emerging strategies like facilitated PCI represent a promising advancement in the rapid treatment of STEMI.
  • Further research is essential to fully establish the role of facilitated PCI in STEMI treatment protocols.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...